Camtek shares rise 3% on strong Q2 beat and robust guidance

Camtek reported Q2 adjusted EPS of $0.78, beating the $0.75 consensus (+$0.03), on record revenue of $133.2M vs the $126.26M estimate (+8% YoY). Management guided Q3 revenue to $158M–$160M (midpoint $159M), well above typical sequential patterns, and expects >30% growth in 2H26 vs 1H26 with continued growth into 2027. The company cited ~$600M in orders since the start of 2026 and completed the Visual Layer acquisition during the quarter; shares rose ~3.6% pre-market.

Analysis

The real signal is that advanced-packaging demand is becoming contracted backlog rather than anecdotal strength. That favors CAMT first, but the second-order winners are the ecosystem names tied to AI packaging capacity such as AMKR, ASX, and, more indirectly, TSM, because inspection/metrology spend typically rises once packaging utilization stays tight. The flip side is that broader semicap names with less AP exposure can lag if investors keep rotating capital toward the narrowest AI bottlenecks.

The near-term risk is that this is still an order-book story, not yet a cash-flow story. Margins already showed some pressure, so if revenue ramps faster than manufacturing throughput, the stock can still de-rate on execution concerns even while growth looks strong. The key falsifier over the next 1-3 months is any sign that the delivery pipeline is push-out-prone or that sequential growth normalizes below management’s implied path.

Consensus is probably underestimating how much of the uplift is structural versus cyclical: once a customer qualifies a packaging node, inspection tools tend to get specified into the next capacity wave, which can extend demand for 6-18 months. But the market may also be over-anchoring on 2027 visibility without discounting customer concentration and timing risk. If AP capex broadens, CAMT has more upside; if AI packaging spend pauses, the multiple can compress quickly because the stock is now priced on future bookings, not just current EPS.

Key Decisions for Investors

• Buy CAMT only on a post-earnings fade or first meaningful pullback; target a 1-3 month rebound into the next guidance/peer-readthrough cycle. Risk/reward is attractive if the market discounts the order book too quickly, but the thesis breaks if the company cannot convert bookings into sequential revenue growth.
• Pair trade: long CAMT / short SOXX to isolate advanced-packaging capex beta from the broader semiconductor cycle. This is the cleanest expression if AI packaging remains the tightest bottleneck over the next 1-2 quarters.
• For second-order exposure, initiate a smaller long in AMKR or ASX on weakness as a beneficiary of packaging-capacity expansion. Use this only if you want a slower-moving 6-18 month theme; it is a weaker but more diversified expression than CAMT.
• If using options, prefer a 3-6 month CAMT call spread rather than outright calls. The trade needs one more confirmation point on order conversion, and the spread limits downside if margins or delivery timing disappoint.
• Set a hard alert if CAMT gives back the post-print breakout or if the next quarter’s margin guide slips below current run-rate. That would suggest the market is paying too much for backlog visibility and not enough for execution risk.